25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

OPT (Opthea) Stock Analysis
Buy, Hold or Sell?

Let's analyze Opthea together

I guess you are interested in Opthea Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Opthea’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Opthea’s Price Targets

I'm going to help you getting a better view of Opthea Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Opthea Ltd

I send you an email if I find something interesting about Opthea Ltd.

1. Quick Overview

1.1. Quick analysis of Opthea (30 sec.)










1.2. What can you expect buying and holding a share of Opthea? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$-0.09
Expected worth in 1 year
A$-0.43
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
A$-0.33
Return On Investment
-55.5%

For what price can you sell your share?

Current Price per Share
A$0.60
Expected price per share
A$0.6 - A$0.6
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Opthea (5 min.)




Live pricePrice per Share (EOD)
A$0.60
Intrinsic Value Per Share
A$-2.87 - A$-1.47
Total Value Per Share
A$-2.96 - A$-1.57

2.2. Growth of Opthea (5 min.)




Is Opthea growing?

Current yearPrevious yearGrowGrow %
How rich?-$75.8m-$8.7m-$67m-88.4%

How much money is Opthea making?

Current yearPrevious yearGrowGrow %
Making money-$220.2m-$211.8m-$8.3m-3.8%
Net Profit Margin-176,665.7%-131,469.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Opthea (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Opthea?

Welcome investor! Opthea's management wants to use your money to grow the business. In return you get a share of Opthea.

First you should know what it really means to hold a share of Opthea. And how you can make/lose money.

Speculation

The Price per Share of Opthea is A$0.6. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Opthea.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Opthea, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$-0.09. Based on the TTM, the Book Value Change Per Share is A$-0.08 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.10 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Opthea.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.18-29.8%-0.18-29.8%-0.12-19.3%-0.12-20.6%-0.08-14.0%-0.05-7.8%
Usd Book Value Change Per Share-0.05-9.1%-0.05-9.1%-0.06-10.6%-0.07-11.6%-0.02-2.9%-0.01-1.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.05-9.1%-0.05-9.1%-0.06-10.6%-0.07-11.6%-0.02-2.9%-0.01-1.2%
Usd Price Per Share0.23-0.23-0.39-0.47-0.80-0.59-
Price to Earnings Ratio-1.28--1.28--3.37--5.01--33.12--42.36-
Price-to-Total Gains Ratio-4.21--4.21--6.12--6.35-10.47--27.57-
Price to Book Ratio-3.72--3.72--54.69--14.87--1.26-7.52-
Price-to-Total Gains Ratio-4.21--4.21--6.12--6.35-10.47--27.57-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.39246
Number of shares2548
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.05-0.02
Usd Total Gains Per Share-0.05-0.02
Gains per Quarter (2548 shares)-138.69-44.26
Gains per Year (2548 shares)-554.74-177.03
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-555-5650-177-187
20-1109-11200-354-364
30-1664-16750-531-541
40-2219-22300-708-718
50-2774-27850-885-895
60-3328-33400-1062-1072
70-3883-38950-1239-1249
80-4438-44500-1416-1426
90-4993-50050-1593-1603
100-5547-55600-1770-1780

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%5.031.00.013.9%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%2.03.00.040.0%4.06.00.040.0%16.020.00.044.4%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%4.00.032.011.1%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%2.03.00.040.0%4.06.00.040.0%17.019.00.047.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Opthea Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.083-0.0830%-0.098+17%-0.106+27%-0.027-68%-0.011-87%
Book Value Per Share---0.094-0.0940%-0.011-88%-0.006-93%0.057-265%0.048-297%
Current Ratio--2.9382.9380%5.249-44%4.387-33%13.586-78%12.499-76%
Debt To Asset Ratio--1.4021.4020%1.059+32%0.887+58%0.557+152%0.338+314%
Debt To Equity Ratio----0%-0%0.084-100%0.077-100%0.109-100%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--290089253.826290089253.8260%700026572.420-59%844329843.269-66%1558142709.921-81%1147445185.383-75%
Eps---0.273-0.2730%-0.177-35%-0.189-31%-0.129-53%-0.071-74%
Ev To Ebitda Ratio---0.952-0.9520%-2.051+115%-3.527+270%-24.118+2433%-30.452+3098%
Ev To Sales Ratio--1522.0641522.0640%2841.178-46%4144.618-63%8262.303-82%4907.308-69%
Free Cash Flow Per Share---0.200-0.2000%-0.223+11%-0.182-9%-0.126-37%-0.070-65%
Free Cash Flow To Equity Per Share--0.1030.1030%0.086+19%0.022+360%0.047+118%0.025+315%
Gross Profit Margin--1.0001.0000%1.107-10%1.058-5%1.057-5%1.071-7%
Intrinsic Value_10Y_max---1.473----------
Intrinsic Value_10Y_min---2.866----------
Intrinsic Value_1Y_max---0.087----------
Intrinsic Value_1Y_min---0.210----------
Intrinsic Value_3Y_max---0.308----------
Intrinsic Value_3Y_min---0.702----------
Intrinsic Value_5Y_max---0.585----------
Intrinsic Value_5Y_min---1.268----------
Market Cap738750028.800+42%430937516.800430937516.8000%735179403.661-41%878866284.262-51%1515200934.070-72%1108506730.715-61%
Net Profit Margin---1766.657-1766.6570%-1314.698-26%-1368.297-23%-975.248-45%-510.053-71%
Operating Margin---1599.404-1599.4040%-1386.480-13%-1350.548-16%-959.907-40%-518.741-68%
Operating Ratio--1539.8541539.8540%1388.100+11%1331.903+16%950.494+62%513.886+200%
Pb Ratio-6.374-71%-3.718-3.7180%-54.689+1371%-14.874+300%-1.260-66%7.519-149%
Pe Ratio-2.194-71%-1.280-1.2800%-3.374+164%-5.006+291%-33.121+2488%-42.365+3210%
Price Per Share0.600+42%0.3500.3500%0.597-41%0.714-51%1.231-72%0.900-61%
Price To Free Cash Flow Ratio-3.000-71%-1.750-1.7500%-2.681+53%-4.736+171%-56.703+3140%-58.852+3262%
Price To Total Gains Ratio-7.210-71%-4.206-4.2060%-6.121+46%-6.346+51%10.467-140%-27.571+556%
Quick Ratio--2.8772.8770%5.109-44%4.079-29%12.461-77%11.771-76%
Return On Assets---1.167-1.1670%-1.430+23%-1.354+16%-0.923-21%-0.625-46%
Return On Equity----0%-0%-0.6110%-0.4840%-0.4340%
Total Gains Per Share---0.083-0.0830%-0.098+17%-0.106+27%-0.027-68%-0.011-87%
Usd Book Value---75809173.344-75809173.3440%-8793071.185-88%-4944454.061-93%46034535.662-265%38559341.567-297%
Usd Book Value Change Per Share---0.054-0.0540%-0.064+17%-0.069+27%-0.017-68%-0.007-87%
Usd Book Value Per Share---0.062-0.0620%-0.007-88%-0.004-93%0.037-265%0.031-297%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--189747380.928189747380.9280%457887381.020-59%552276150.482-66%1019181146.560-81%750543895.759-75%
Usd Eps---0.179-0.1790%-0.116-35%-0.123-31%-0.084-53%-0.047-74%
Usd Free Cash Flow---161046923.298-161046923.2980%-179334393.309+11%-146256853.931-9%-101618613.376-37%-56703568.927-65%
Usd Free Cash Flow Per Share---0.131-0.1310%-0.146+11%-0.119-9%-0.083-37%-0.046-65%
Usd Free Cash Flow To Equity Per Share--0.0670.0670%0.056+19%0.015+360%0.031+118%0.016+315%
Usd Market Cap483216393.838+42%281876229.739281876229.7390%480880847.935-41%574866436.536-51%991092930.975-72%725074252.561-61%
Usd Price Per Share0.392+42%0.2290.2290%0.391-41%0.467-51%0.805-72%0.589-61%
Usd Profit---220239479.714-220239479.7140%-211878154.382-4%-186702107.484-15%-127402188.148-42%-69159727.467-69%
Usd Revenue--124664.514124664.5140%161161.079-23%136957.034-9%129749.653-4%418272.314-70%
Usd Total Gains Per Share---0.054-0.0540%-0.064+17%-0.069+27%-0.017-68%-0.007-87%
 EOD+6 -2MRQTTM+0 -0YOY+13 -233Y+11 -265Y+6 -3110Y+7 -30

3.3 Fundamental Score

Let's check the fundamental score of Opthea Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.194
Price to Book Ratio (EOD)Between0-1-6.374
Net Profit Margin (MRQ)Greater than0-1,766.657
Operating Margin (MRQ)Greater than0-1,599.404
Quick Ratio (MRQ)Greater than12.877
Current Ratio (MRQ)Greater than12.938
Debt to Asset Ratio (MRQ)Less than11.402
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-1.167
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Opthea Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.600
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Opthea Ltd

Opthea Limited, a clinical-stage biopharmaceutical company, develops and commercializes drugs for eye diseases in Australia and the United States. Its development activities are based on the intellectual property portfolio covering vascular endothelial growth factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company's lead product candidate is sozinibercept (OPT-302), a biologic drug in Phase 3 clinical trials designed to inhibit VEGF-C and VEGF-D and complement VEGF-A inhibitors for the treatment of wet age-related macular degeneration and diabetic macular edema. It serves the biotechnology and healthcare industries. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated in 1984 and is headquartered in South Yarra, Australia.

Fundamental data was last updated by Penke on 2025-07-11 11:47:07.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Opthea earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Opthea to theΒ Biotechnology industry mean.
  • A Net Profit Margin of -176,665.7%Β means thatΒ $-1,766.66 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Opthea Ltd:

  • The MRQ is -176,665.7%. The company is making a huge loss. -2
  • The TTM is -176,665.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-176,665.7%TTM-176,665.7%0.0%
TTM-176,665.7%YOY-131,469.8%-45,195.9%
TTM-176,665.7%5Y-97,524.8%-79,141.0%
5Y-97,524.8%10Y-51,005.3%-46,519.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-176,665.7%-93.6%-176,572.1%
TTM-176,665.7%-140.9%-176,524.8%
YOY-131,469.8%-197.6%-131,272.2%
3Y-136,829.7%-248.5%-136,581.2%
5Y-97,524.8%-343.4%-97,181.4%
10Y-51,005.3%-496.2%-50,509.1%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Opthea is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Opthea to theΒ Biotechnology industry mean.
  • -116.7% Return on Assets means thatΒ Opthea generatedΒ $-1.17 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Opthea Ltd:

  • The MRQ is -116.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -116.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-116.7%TTM-116.7%0.0%
TTM-116.7%YOY-143.0%+26.3%
TTM-116.7%5Y-92.3%-24.3%
5Y-92.3%10Y-62.5%-29.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-116.7%-11.6%-105.1%
TTM-116.7%-11.6%-105.1%
YOY-143.0%-11.4%-131.6%
3Y-135.4%-11.8%-123.6%
5Y-92.3%-12.0%-80.3%
10Y-62.5%-13.7%-48.8%
4.3.1.3. Return on Equity

Shows how efficient Opthea is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Opthea to theΒ Biotechnology industry mean.
  • 0.0% Return on Equity means Opthea generated $0.00Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Opthea Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-48.4%+48.4%
5Y-48.4%10Y-43.4%-5.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--13.5%+13.5%
TTM--14.9%+14.9%
YOY--14.6%+14.6%
3Y-61.1%-16.8%-44.3%
5Y-48.4%-17.5%-30.9%
10Y-43.4%-19.9%-23.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Opthea Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Opthea is operatingΒ .

  • Measures how much profit Opthea makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Opthea to theΒ Biotechnology industry mean.
  • An Operating Margin of -159,940.4%Β means the company generated $-1,599.40 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Opthea Ltd:

  • The MRQ is -159,940.4%. The company is operating very inefficient. -2
  • The TTM is -159,940.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-159,940.4%TTM-159,940.4%0.0%
TTM-159,940.4%YOY-138,648.0%-21,292.4%
TTM-159,940.4%5Y-95,990.7%-63,949.7%
5Y-95,990.7%10Y-51,874.1%-44,116.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-159,940.4%-232.5%-159,707.9%
TTM-159,940.4%-250.5%-159,689.9%
YOY-138,648.0%-209.2%-138,438.8%
3Y-135,054.8%-234.1%-134,820.7%
5Y-95,990.7%-346.1%-95,644.6%
10Y-51,874.1%-477.5%-51,396.6%
4.3.2.2. Operating Ratio

Measures how efficient Opthea is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 1,539.85 means that the operating costs are $1,539.85 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Opthea Ltd:

  • The MRQ is 1,539.854. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1,539.854. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1,539.854TTM1,539.8540.000
TTM1,539.854YOY1,388.100+151.753
TTM1,539.8545Y950.494+589.360
5Y950.49410Y513.886+436.608
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1,539.8542.111+1,537.743
TTM1,539.8542.694+1,537.160
YOY1,388.1003.096+1,385.004
3Y1,331.9033.652+1,328.251
5Y950.4944.745+945.749
10Y513.8866.614+507.272
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Opthea Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Opthea is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 2.94Β means the company has $2.94 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Opthea Ltd:

  • The MRQ is 2.938. The company is able to pay all its short-term debts. +1
  • The TTM is 2.938. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.938TTM2.9380.000
TTM2.938YOY5.249-2.311
TTM2.9385Y13.586-10.648
5Y13.58610Y12.499+1.087
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.9383.661-0.723
TTM2.9383.846-0.908
YOY5.2494.140+1.109
3Y4.3874.688-0.301
5Y13.5865.746+7.840
10Y12.4996.147+6.352
4.4.3.2. Quick Ratio

Measures if Opthea is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Opthea to theΒ Biotechnology industry mean.
  • A Quick Ratio of 2.88Β means the company can pay off $2.88 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Opthea Ltd:

  • The MRQ is 2.877. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.877. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.877TTM2.8770.000
TTM2.877YOY5.109-2.232
TTM2.8775Y12.461-9.584
5Y12.46110Y11.771+0.690
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8772.848+0.029
TTM2.8773.169-0.292
YOY5.1093.786+1.323
3Y4.0794.311-0.232
5Y12.4615.703+6.758
10Y11.7716.368+5.403
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Opthea Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of OptheaΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Opthea to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.40Β means that Opthea assets areΒ financed with 140.2% credit (debt) and the remaining percentage (100% - 140.2%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Opthea Ltd:

  • The MRQ is 1.402. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.402. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.402TTM1.4020.000
TTM1.402YOY1.059+0.342
TTM1.4025Y0.557+0.845
5Y0.55710Y0.338+0.218
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4020.329+1.073
TTM1.4020.349+1.053
YOY1.0590.331+0.728
3Y0.8870.340+0.547
5Y0.5570.349+0.208
10Y0.3380.379-0.041
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Opthea is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Opthea to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Opthea Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.077-0.077
5Y0.07710Y0.109-0.032
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.379-0.379
TTM-0.437-0.437
YOY-0.414-0.414
3Y0.0840.450-0.366
5Y0.0770.464-0.387
10Y0.1090.515-0.406
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Opthea generates.

  • Above 15 is considered overpriced butΒ always compareΒ Opthea to theΒ Biotechnology industry mean.
  • A PE ratio of -1.28 means the investor is paying $-1.28Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Opthea Ltd:

  • The EOD is -2.194. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.280. Based on the earnings, the company is expensive. -2
  • The TTM is -1.280. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.194MRQ-1.280-0.914
MRQ-1.280TTM-1.2800.000
TTM-1.280YOY-3.374+2.094
TTM-1.2805Y-33.121+31.841
5Y-33.12110Y-42.365+9.244
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.194-2.356+0.162
MRQ-1.280-2.077+0.797
TTM-1.280-2.574+1.294
YOY-3.374-3.760+0.386
3Y-5.006-3.773-1.233
5Y-33.121-6.193-26.928
10Y-42.365-6.876-35.489
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Opthea Ltd:

  • The EOD is -3.000. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.750. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.750. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.000MRQ-1.750-1.250
MRQ-1.750TTM-1.7500.000
TTM-1.750YOY-2.681+0.931
TTM-1.7505Y-56.703+54.953
5Y-56.70310Y-58.852+2.148
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.000-3.246+0.246
MRQ-1.750-2.705+0.955
TTM-1.750-3.704+1.954
YOY-2.681-4.402+1.721
3Y-4.736-5.070+0.334
5Y-56.703-8.477-48.226
10Y-58.852-9.305-49.547
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Opthea is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of -3.72 means the investor is paying $-3.72Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Opthea Ltd:

  • The EOD is -6.374. Based on the equity, the company is expensive. -2
  • The MRQ is -3.718. Based on the equity, the company is expensive. -2
  • The TTM is -3.718. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.374MRQ-3.718-2.656
MRQ-3.718TTM-3.7180.000
TTM-3.718YOY-54.689+50.970
TTM-3.7185Y-1.260-2.458
5Y-1.26010Y7.519-8.779
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-6.3742.038-8.412
MRQ-3.7181.843-5.561
TTM-3.7182.125-5.843
YOY-54.6892.442-57.131
3Y-14.8742.492-17.366
5Y-1.2603.652-4.912
10Y7.5194.311+3.208
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Opthea Ltd.

4.8.2. Funds holding Opthea Ltd

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-06-302021-06-302022-06-302023-06-302024-06-30
Gross Profit  -568-166-734570-16428-137327191



5.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets188,791
Total Liabilities264,601
Total Stockholder Equity-75,810
 As reported
Total Liabilities 264,601
Total Stockholder Equity+ -75,810
Total Assets = 188,791

Assets

Total Assets188,791
Total Current Assets188,193
Long-term Assets599
Total Current Assets
Cash And Cash Equivalents 172,471
Net Receivables 11,824
Other Current Assets 3,897
Total Current Assets  (as reported)188,193
Total Current Assets  (calculated)188,193
+/-0
Long-term Assets
Property Plant Equipment 132
Long-term Assets Other 467
Long-term Assets  (as reported)599
Long-term Assets  (calculated)599
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities64,056
Long-term Liabilities200,546
Total Stockholder Equity-75,810
Total Current Liabilities
Short-term Debt 93
Accounts payable 38,060
Other Current Liabilities 25,858
Total Current Liabilities  (as reported)64,056
Total Current Liabilities  (calculated)64,011
+/- 45
Long-term Liabilities
Long term Debt 141,555
Long-term Liabilities Other 58,981
Long-term Liabilities  (as reported)200,546
Long-term Liabilities  (calculated)200,536
+/- 10
Total Stockholder Equity
Common Stock466,084
Retained Earnings -579,705
Accumulated Other Comprehensive Income 37,810
Total Stockholder Equity (as reported)-75,810
Total Stockholder Equity (calculated)-75,810
+/-0
Other
Capital Stock466,084
Cash and Short Term Investments 172,471
Common Stock Shares Outstanding 638,203
Current Deferred Revenue1,062
Liabilities and Stockholders Equity 188,791
Net Debt -30,824
Net Invested Capital 65,745
Net Working Capital 124,137
Property Plant and Equipment Gross 132
Short Long Term Debt Total 141,648



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-301999-06-301998-06-301997-06-301996-06-301995-06-301994-06-301993-06-301992-06-301991-06-301990-06-301989-06-30
> Total Assets 
2,445
1,531
1,322
1,669
1,637
2,126
2,143
3,930
5,491
4,491
7,298
15,217
24,366
23,488
24,833
29,464
32,917
43,787
56,708
51,523
33,314
29,464
26,187
23,134
14,978
11,732
18,464
17,053
56,545
46,076
37,660
71,887
184,361
87,322
148,188
188,791
188,791148,18887,322184,36171,88737,66046,07656,54517,05318,46411,73214,97823,13426,18729,46433,31451,52356,70843,78732,91729,46424,83323,48824,36615,2177,2984,4915,4913,9302,1432,1261,6371,6691,3221,5312,445
   > Total Current Assets 
1,377
374
231
606
551
663
647
2,229
3,170
2,196
5,063
8,596
13,211
11,385
10,054
12,457
19,163
21,118
41,317
45,041
31,817
27,438
23,933
18,595
12,294
9,397
16,814
16,646
55,333
45,213
36,892
71,317
183,973
87,121
147,805
188,193
188,193147,80587,121183,97371,31736,89245,21355,33316,64616,8149,39712,29418,59523,93327,43831,81745,04141,31721,11819,16312,45710,05411,38513,2118,5965,0632,1963,1702,2296476635516062313741,377
       Cash And Cash Equivalents 
26
5
200
520
680
31
39
9
107
86
109,602
275
12,968
11,263
9,892
12,187
18,818
10,839
40,876
44,218
31,343
27,073
23,624
16,824
10,042
6,743
14,140
14,486
51,960
32,510
21,535
62,020
157,433
64,904
133,987
172,471
172,471133,98764,904157,43362,02021,53532,51051,96014,48614,1406,74310,04216,82423,62427,07331,34344,21840,87610,83918,81812,1879,89211,26312,968275109,6028610793931680520200526
       Short-term Investments 
400
48
71
154
83
0
0
0
-506
1,900
4,918,478
8,239
103
72
47
28
14
9,898
12
0
0
0
0
0
0
0
0
126
0
0
0
0
0
0
0
0
0000000012600000000129,898142847721038,2394,918,4781,900-506000831547148400
       Net Receivables 
60
19
7
63
14
18
40
54
2,709
21
24
68
129
32
64
62
86
83
266
259
383
304
223
1,695
332
390
180
1,977
3,219
12,411
14,933
8,818
7,377
9,535
9,859
11,824
11,8249,8599,5357,3778,81814,93312,4113,2191,9771803903321,69522330438325926683866264321296824212,709544018146371960
       Other Current Assets 
892
0
153
0
0
614
0
0
354
189
15,798
15
25
36
105
506
300
596
305
619
182
122
86
76
1,920
2,264
108
1,990
3,373
12,703
15,357
479
20
8,720
3,958
3,897
3,8973,9588,7202047915,35712,7033,3731,9901082,2641,920768612218261930559630050610536251515,79818935400614001530892
   > Long-term Assets 
1,068
1,126
1,091
1,063
1,086
1,462
1,496
1,700
2,320
2,295
2,235
6,621
11,155
12,103
14,778
17,007
13,754
22,669
15,391
6,483
1,497
2,026
2,254
4,539
2,683
2,335
1,650
407
1,212
862
768
571
388
201
383
599
5993832013885717688621,2124071,6502,3352,6834,5392,2542,0261,4976,48315,39122,66913,75417,00714,77812,10311,1556,6212,2352,2952,3201,7001,4961,4621,0861,0631,0911,1261,068
       Property Plant Equipment 
2
2
1
0
0
7
7
12
114
94
82,364
51
53
44
49
35
29
33
69
76
54
46
104
109
75
140
85
91
64
69
54
281
156
41
303
132
13230341156281546964918514075109104465476693329354944535182,36494114127700122
       Goodwill 
11
11
9
8
6
6
5
39
29
17
11
0
0
0
0
0
149
111
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000001111490000011172939566891111
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,275
2,041
316
1,148
793
714
290
0
0
0
0
00002907147931,1483162,0412,2750000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
38
27
16,017
0
0
0
0
0
195
149
0
0
0
0
0
512
456
0
0
0
0
0
0
0
0
0
0
0
00000000000456512000001491950000016,017273800000000
       Long-term Assets Other 
47
39
31
0
0
8
1
87
87
74
70
373
278
307
367
381
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-768
0
232
160
80
467
467801602320-76800000000000000381367307278373707487871800313947
> Total Liabilities 
35
25
29
39
21
32
69
95
167
162
142
218
166
209
318
312
4,289
1,720
4,998
2,339
2,022
2,421
2,862
2,464
1,874
1,866
1,803
2,074
2,053
7,903
6,541
7,079
4,160
17,552
156,981
264,601
264,601156,98117,5524,1607,0796,5417,9032,0532,0741,8031,8661,8742,4642,8622,4212,0222,3394,9981,7204,2893123182091662181421621679569322139292535
   > Total Current Liabilities 
35
25
29
39
21
32
66
90
164
154
92
175
99
106
306
302
4,270
974
2,634
1,709
1,882
2,259
2,603
2,175
1,743
1,662
1,724
2,012
2,003
7,864
6,516
6,919
4,138
17,511
28,157
64,056
64,05628,15717,5114,1386,9196,5167,8642,0032,0121,7241,6621,7432,1752,6032,2591,8821,7092,6349744,27030230610699175921541649066322139292535
       Short-term Debt 
530
61
8
20
1
0
0
10
3
0
4,918
13,800
201
128
69
40
3,812
13,338
14
0
0
0
0
0
0
0
0
169
0
0
0
100
113
0
146
93
931460113100000169000000001413,3383,812406912820113,8004,918031000120861530
       Accounts payable 
0
0
0
0
0
0
0
0
112
87
59,166
146
65
47
102
90
212
570
1,843
1,314
1,407
1,800
2,134
1,717
1,226
1,249
1,315
1,183
1,196
5,306
5,896
4,054
2,418
11,402
26,805
38,060
38,06026,80511,4022,4184,0545,8965,3061,1961,1831,3151,2491,2261,7172,1341,8001,4071,3141,84357021290102476514659,1668711200000000
       Other Current Liabilities 
35
25
21
19
21
32
66
80
81
95
92
175
99
107
306
302
457
404
791
396
924
859
470
458
685
516
409
783
760
2,506
564
2,708
1,496
6,046
1,132
25,858
25,8581,1326,0461,4962,7085642,506760783409516685458470859924396791404457302306107991759295818066322119212535
   > Long-term Liabilities 
530
61
8
20
1
0
3
6
3
8
50
44
67
102
12
10
19
746
2,365
630
141
161
259
289
130
204
79
62
50
39
25
160
23
41
128,824
200,546
200,546128,824412316025395062792041302892591611416302,36574619101210267445083630120861530
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
120
0
0
85,744
0
085,744001200000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
73
131
182
18
15
25
36
29
10
21
35
53
106
65
161
103
62
50
39
25
40
17
28
8
0
0828174025395062103161651065335211029362515181821317300000000000
> Total Stockholder Equity
2,446
1,505
1,317
1,648
1,627
2,099
2,075
3,830
5,324
4,329
7,156
14,999
23,972
23,279
24,514
29,151
28,520
41,993
47,367
45,374
31,272
27,043
23,325
19,354
12,276
8,977
16,033
14,978
54,492
38,172
31,120
64,808
180,201
69,770
-8,793
-75,810
-75,810-8,79369,770180,20164,80831,12038,17254,49214,97816,0338,97712,27619,35423,32527,04331,27245,37447,36741,99328,52029,15124,51423,27923,97214,9997,1564,3295,3243,8302,0752,0991,6271,6481,3171,5052,446
   Common Stock
1,690
1,433
1,385
1,629
1,601
1,824
1,817
2,211
2,222
1,899
7,155
16,004
25,632
28,344
32,939
33,836
25,290
24,612
28,132
31,733
30,970
32,613
41,013
40,317
36,005
37,146
41,296
53,845
97,853
98,403
113,022
162,103
311,885
342,147
482,060
466,084
466,084482,060342,147311,885162,103113,02298,40397,85353,84541,29637,14636,00540,31741,01332,61330,97031,73328,13224,61225,29033,83632,93928,34425,63216,0047,1551,8992,2222,2111,8171,8241,6011,6291,3851,4331,690
   Retained Earnings 
-39
-526
-647
-691
-959
-1,095
-1,562
-2,590
-3,532
-4,139
-2,869
-1,835
-2,370
-5,848
-9,362
-5,658
2,168
2,841
12,750
13,283
3,202
-2,534
-14,158
-14,828
-17,562
-21,880
-21,764
-42,055
-48,248
-65,150
-86,060
-102,589
-165,333
-315,482
-540,017
-579,705
-579,705-540,017-315,482-165,333-102,589-86,060-65,150-48,248-42,055-21,764-21,880-17,562-14,828-14,158-2,5343,20213,28312,7502,8412,168-5,658-9,362-5,848-2,370-1,835-2,869-4,139-3,532-2,590-1,562-1,095-959-691-647-526-39
   Accumulated Other Comprehensive Income 
796
599
579
710
985
1,370
1,820
4,208
7,062
7,939
734,407
831
710
783
937
973
1,061
14,540
6,485
357
-2,899
-3,036
-3,530
-6,136
-6,168
-6,288
-3,499
3,188
4,886
4,919
4,158
5,295
33,649
43,105
49,164
37,810
37,81049,16443,10533,6495,2954,1584,9194,8863,188-3,499-6,288-6,168-6,136-3,530-3,036-2,8993576,48514,5401,061973937783710831734,4077,9397,0624,2081,8201,370985710579599796
   Capital Surplus 000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-06-30. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue125
Cost of Revenue--
Gross Profit125125
 
Operating Income (+$)
Gross Profit125
Operating Expense-191,967
Operating Income-191,843-191,843
 
Operating Expense (+$)
Research Development176,326
Selling General Administrative15,489
Selling And Marketing Expenses-
Operating Expense191,967191,815
 
Net Interest Income (+$)
Interest Income3,395
Interest Expense-30,263
Other Finance Cost-0
Net Interest Income-26,868
 
Pretax Income (+$)
Operating Income-191,843
Net Interest Income-26,868
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-229,654-154,031
EBIT - interestExpense = -229,654
-229,654
-189,979
Interest Expense30,263
Earnings Before Interest and Taxes (EBIT)-199,391-199,391
Earnings Before Interest and Taxes (EBITDA)-199,288
 
After tax Income (+$)
Income Before Tax-229,654
Tax Provision--9,412
Net Income From Continuing Ops-220,242-220,242
Net Income-220,242
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses191,967
Total Other Income/Expenses Net-37,81226,868
 

Technical Analysis of Opthea
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Opthea. The general trend of Opthea is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Opthea's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Opthea Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Opthea Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.6 < 0.6 < 0.6.

The bearish price targets are: 0.6 > 0.6 > 0.6.

Know someone who trades $OPT? Share this with them.πŸ‘‡

Opthea Ltd Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Opthea Ltd. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Opthea Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Opthea Ltd.

Opthea Ltd Daily Moving Average Convergence/Divergence (MACD) ChartOpthea Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Opthea Ltd. The current adx is .

Opthea Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Opthea Ltd.

Opthea Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Opthea Ltd.

Opthea Ltd Daily Relative Strength Index (RSI) ChartOpthea Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Opthea Ltd.

Opthea Ltd Daily Stochastic Oscillator ChartOpthea Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Opthea Ltd.

Opthea Ltd Daily Commodity Channel Index (CCI) ChartOpthea Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Opthea Ltd.

Opthea Ltd Daily Chande Momentum Oscillator (CMO) ChartOpthea Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Opthea Ltd.

Opthea Ltd Daily Williams %R ChartOpthea Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Opthea Ltd.

Opthea Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Opthea Ltd.

Opthea Ltd Daily Average True Range (ATR) ChartOpthea Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Opthea Ltd.

Opthea Ltd Daily On-Balance Volume (OBV) ChartOpthea Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Opthea Ltd.

Opthea Ltd Daily Money Flow Index (MFI) ChartOpthea Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Opthea Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-03-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-05BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-13STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-14MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-19MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.

6.3. Candlestick Patterns

Opthea Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Opthea Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.600
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Opthea with someone you think should read this too:
  • Are you bullish or bearish on Opthea? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Opthea? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Opthea Ltd

I send you an email if I find something interesting about Opthea Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Opthea Ltd.

Receive notifications about Opthea Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.